Cargando…
Targeting breast cancer vaccines to dendritic cells: improved immunological responses with less protein?
The central goal of cancer immunotherapy is to control tumors through the mobilization of the patient's immune system. Vaccines targeting the Her2/neu proto-oncogene have been tested with some early encouraging responses in breast cancer. However, a more effective set of vaccines targeting spec...
Autores principales: | Armstrong, Anne C, Gilham, David E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446337/ https://www.ncbi.nlm.nih.gov/pubmed/22643384 http://dx.doi.org/10.1186/bcr3184 |
Ejemplares similares
-
Immunologic Monitoring of Cellular Immune Responses in Cancer Vaccine Therapy
por: Whiteside, Theresa L., et al.
Publicado: (2011) -
Immunologic Monitoring of Cellular Responses by Dendritic/Tumor Cell Fusion Vaccines
por: Koido, Shigeo, et al.
Publicado: (2011) -
Immunological Responses to Cancer Therapy
por: Fransen, Marieke F.
Publicado: (2022) -
Immunological effects of chemotherapy in spontaneous breast cancers
por: Kroemer, Guido, et al.
Publicado: (2013) -
Molecular Immunology in Bacterial Vaccine Discovery
por: Berisio, Rita
Publicado: (2022)